Bactiguard enters distribution agreement for Israel

Bactiguard has entered an exclusive distribution agreement for Israel with Dover
Medical & Scientific Equipment Ltd. The agreement covers sales of all products
in the Bactiguard Infection Protection portfolio.
“Changing our market strategy for Israel from direct sales to sales via a
distributor is a more cost efficient way of expanding our presence and sales in
this market. The number of patients that die from infections caused by resistant
bacteria in Israeli hospitals is estimated to more than 4 000 per year, so there
is a great need for preventive solutions”, says Niels Christiansen, CEO.
Israel has a population of 8 million people and almost 8 percent of GDP is spent
on healthcare. Offering preventive solutions, such as Bactiguard® -coated
catheters for the urinary- and respiratory tracts and the bloodstream is vital
to combat healthcare associated infections.
The distributor in Israel, Dover Medical & Scientific Equipment, Ltd., is a
family owned company founded in 1974. It is one of the leading companies in the
Israeli market for medical devices with customers such as: Ministry of Health
Hospitals, University Hospitals, Private Hospitals, Clinics and Research
Institutes. Dover focuses on medical and diagnostic solutions.
For further information, please contact:
Cecilia Edström, Acting Director of Sales, Marketing & Communications, mobile:
+46 722 262 328
About Bactiguard
Bactiguard is a Swedish medtech company with a mission of preventing healthcare
associated infections, reducing the use of antibiotics and saving lives by
developing and supplying infection prevention solutions for the healthcare
industry. The company’s patented coating prevents healthcare associated
infections by reducing bacterial adhesion and growth on medical devices.
Bactiguard®-coated urinary catheters are market leading in the US and Japan, and
in recent years the company has developed its own product portfolio of catheters
for the urinary and respiratory tract and the blood stream. Bactiguard is
currently in a strong expansion phase, focused on new markets in the Europe,
Middle East, Asia, Latin America and Southern Africa. The company has market
presence in some 50 countries and has about 60 employees. Its headquarters is
located in Stockholm and production facilities in Sweden and Malaysia.
Bactiguard is listed on Nasdaq Stockholm. Read more about Bactiguard at
www.bactiguard.com